We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Actve is on a mission to change the way people connect with their favourite fitness creators. The company aspires to help creators earn an income and build a subscription business. Actve asserts that it caters to a variety of creator needs allowing them to live-stream their workouts, offer guided programs to customers, or use Actve's software to manage their clients. The company aims to become a contender in the digital fitness market that is projected to be worth £21 billion by 2022. It aims to launch its platform in September 2021. Actve will use the investment to develop its platform, hire key staff, build its user base, and work towards becoming an industry champion for fitness creators.
days to go: Expired investment: £165,627
Monva is a financial technology platform that uses Artificial Intelligence (AI) to revolutionise the price comparison experience and personalise customer offers. It argues that only 38% of people in the UK trust Price Comparison Websites (PCWs) with the majority being wary of such entities. Monva aims to change that. Its AI Chatbot ‘Mo’ helps customers save time by suggesting search queries, highlighting key information to assist in making switching decisions, and providing alerts to new automated offers. The company has raised £625,000 in 2020 from DBW, Angels and crowdfunding sites. It was also overfunded by >200%. It aims to become a contender in the price comparison market valued at £2.8 billion. It will use the investment to continue building its smart comparison technology, secure commercial partnerships, and grow its marketing activity.
days to go: Expired investment: £451,905
By combining fitness with fashion, art and design, BLOK has become a major competitor of boutique class-based gyms within London. BLOK has appeared on Britain's Next Top Model, as well as working with global stars including Anthony Joshua and Jordan Dunn.

Pitch Rated

60%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £891,790
Total Be wants to bring an internationally recognised model of car insurance to the UK. It provides insurance for the car, not just for an individual driver. Additionally, it does not take crime data into account that is not specific to vehicles. Thus, this insurance is estimated to provide up to 25% cheaper cover in comparison to UK insurance. Moreover, a UK Government Petition for this insurance model has gained over 60,000+ signatures, which further validates the demand of this model. Total Be believes that it will be able to disrupt the UK market with this car insurance model.
days to go: Expired investment: £150,760
Monva is an FCA approved, customer-centric intelligent comparison platform for financial products and services. It combines Artificial Intelligence (AI), machine learning and smart technology to enable its customers to select the most accurate financial product they wish to buy or invest in. Monva is initially targeting the Credit Card market, which will be followed by Loans, Energy, and Communications, which already represents a potential £3 billion opportunity. The company is targeting 80% of the adults in the UK market that have either never switched a financial product or switched only once. With the investment, the company will build the platform to make it more user friendly, develop strategic partnerships, and recruit staff who specialise technology and marketing.

Pitch Rated

75%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £479,440
Mishergas are a green development company, turning waste tyres into green energy. By cleaning up environmental hazards such as waste tyres and processing them in an environmentally friendly way Mishergas are able to provide solutions to the problem of both waste and energy usage. 
days to go: Expired investment: £347,575
Nomisma is a cloud based platform that provide accounting capability for accountants and can be accessed from anywhere using any device. Nomisma was designed to reduce operating cocts by cutting down on softwares costs.  
days to go: Expired investment: £81,431
Doctaly is  the brand new healthcare platform providing the quickest way to find and book an affordable, face-to-face, same day GP appointment. Choose from their trusted private doctors, at a convenient time and location from just £39.99.
days to go: Expired investment: £807,580
Scribestar's Software-as-a-Service (SaaS) platform digitises and automates the documentation and compliance processes required for raising capital on stock markets such as IPOs, bonds etc. The platform intends to provide users with structured data format documents that can be machine-read and monetised. Scribestar aims to become a contender in the $22 billion Regulatory/Legal Technology markets. It argues that it is already active in the UK and has witnessed over 50 transactions on its system. It is also a part of the London Stock Exchange Issuer Services and CMS equIP with 4 years of verifiable commercial use and over £13 million received as investments. Scribestar asserts that its services are being regularly used by three law firms in the UK with more showing interest in its capability to function as a remote tool to manage the compliance documentation process. The company will use the investment to start its expansion in the US and other markets targeting law firms and deliver successful trials with stock exchanges.

Pitch Rated

56%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £864,009
Clinical Net is a health-tech firm focused on revolutionizing access to innovative clinical trials. Their AI platform swiftly connects patients with suitable trials, addressing the challenge of low participation rates and delays that hinder pharmaceutical research. With over 69,000 trials globally, their solution aims to streamline the cumbersome and time-consuming process of trial matching, making it more efficient and accessible within 5 minutes. This innovative approach targets the $3.73 billion patient recruitment market while ensuring individuals have easier access to groundbreaking treatments.
days to go: Expired investment: £136,827
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph